Cellular Biomedicine Group, Inc.
(NASDAQ : CBMG)

( )
CBMG PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -6.45%171.140.0%$784.22m
AMGNAmgen, Inc. 0.43%248.361.5%$592.28m
VRTXVertex Pharmaceuticals, Inc. 1.66%298.831.9%$438.24m
GILDGilead Sciences, Inc. 0.65%62.001.0%$379.78m
REGNRegeneron Pharmaceuticals, Inc. -1.35%622.152.6%$351.29m
NVAXNovavax, Inc. -29.64%40.2875.7%$335.10m
SNSSSunesis Pharmaceuticals, Inc. -12.15%3.470.7%$242.57m
ILMNIllumina, Inc. -3.67%214.803.3%$229.68m
BIIBBiogen, Inc. 0.01%217.591.8%$197.59m
BNTXBioNTech SE -7.14%157.210.0%$155.97m
GOVXGeoVax Labs, Inc. -0.35%2.860.0%$145.88m
CRSPCRISPR Therapeutics AG -7.69%75.130.6%$117.81m
PLRXPliant Therapeutics, Inc. 11.19%21.160.0%$108.38m
RYTMRhythm Pharmaceuticals, Inc. 7.19%22.650.0%$105.42m
BMRNBioMarin Pharmaceutical, Inc. 0.00%95.704.2%$98.26m

Company Profile

Cellular Biomedicine Group is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. It is the result of the acquisition, transfer, commercialization, and advancement of thirty years of research and human treatment experience in cellular medicine. Its cellular research and development is the result of collaboration among scientists and doctors from the US, England, and China.